$112.50
0.12% today
NYSE, Apr 02, 10:00 pm CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Target price 2025 - Analyst rating & recommendation

Zimmer Biomet Holdings, Inc. Classifications & Recommendation:

Buy
41%
Hold
53%
Sell
6%

Zimmer Biomet Holdings, Inc. Price Target

Target Price $120.20
Price $112.50
Potential
Number of Estimates 25
25 Analysts have issued a price target Zimmer Biomet Holdings, Inc. 2026 . The average Zimmer Biomet Holdings, Inc. target price is $120.20. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 32 analysts: 13 Analysts recommend Zimmer Biomet Holdings, Inc. to buy, 17 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Zimmer Biomet Holdings, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Zimmer Biomet Holdings, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 7.68 7.89
3.85% 2.79%
EBITDA Margin 30.80% 34.39%
2.61% 11.64%
Net Margin 11.49% 12.11%
12.58% 5.43%

26 Analysts have issued a sales forecast Zimmer Biomet Holdings, Inc. 2025 . The average Zimmer Biomet Holdings, Inc. sales estimate is

$7.9b
Unlock
. This is
2.79% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$8.1b 4.89%
Unlock
, the lowest is
$7.8b 1.79%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $7.7b 3.85%
2025
$7.9b 2.79%
Unlock
2026
$8.3b 4.64%
Unlock
2027
$8.6b 4.38%
Unlock
2028
$9.1b 5.07%
Unlock
2029
$9.6b 6.11%
Unlock

13 Analysts have issued an Zimmer Biomet Holdings, Inc. EBITDA forecast 2025. The average Zimmer Biomet Holdings, Inc. EBITDA estimate is

$2.7b
Unlock
. This is
14.55% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.9b 21.50%
Unlock
, the lowest is
$2.6b 11.20%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $2.4b 1.14%
2025
$2.7b 14.75%
Unlock
2026
$2.9b 6.50%
Unlock
2027
$2.9b 1.13%
Unlock
2028
$3.2b 9.58%
Unlock
2029
$3.4b 6.65%
Unlock

EBITDA Margin

2024 30.80% 2.61%
2025
34.39% 11.64%
Unlock
2026
35.00% 1.77%
Unlock
2027
33.91% 3.11%
Unlock
2028
35.36% 4.28%
Unlock
2029
35.54% 0.51%
Unlock

10 Zimmer Biomet Holdings, Inc. Analysts have issued a net profit forecast 2025. The average Zimmer Biomet Holdings, Inc. net profit estimate is

$955m
Unlock
. This is
8.09% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.2b 36.26%
Unlock
, the lowest is
$741m 16.22%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $882m 9.22%
2025
$955m 8.33%
Unlock
2026
$1.1b 19.19%
Unlock
2027
$1.5b 34.79%
Unlock
2028
$1.6b 2.34%
Unlock

Net Margin

2024 11.49% 12.58%
2025
12.11% 5.43%
Unlock
2026
13.79% 13.87%
Unlock
2027
17.81% 29.15%
Unlock
2028
17.34% 2.64%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 4.43 4.80
9.22% 8.35%
P/E 23.42
EV/Sales 3.58

10 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast for earnings per share. The average Zimmer Biomet Holdings, Inc. EPS is

$4.80
Unlock
. This is
8.11% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$6.05 36.26%
Unlock
, the lowest is
$3.72 16.22%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $4.43 9.22%
2025
$4.80 8.35%
Unlock
2026
$5.72 19.17%
Unlock
2027
$7.71 34.79%
Unlock
2028
$7.89 2.33%
Unlock

P/E ratio

Current 25.33 6.19%
2025
23.42 7.54%
Unlock
2026
19.65 16.10%
Unlock
2027
14.57 25.85%
Unlock
2028
14.24 2.26%
Unlock

Based on analysts' sales estimates for 2025, the Zimmer Biomet Holdings, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.68 16.74%
2025
3.58 2.75%
Unlock
2026
3.42 4.44%
Unlock
2027
3.28 4.19%
Unlock
2028
3.12 4.83%
Unlock
2029
2.94 5.76%
Unlock

P/S ratio

Current 2.91 20.42%
2025
2.83 2.71%
Unlock
2026
2.71 4.44%
Unlock
2027
2.59 4.19%
Unlock
2028
2.47 4.83%
Unlock
2029
2.33 5.76%
Unlock

Current Zimmer Biomet Holdings, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barclays
Locked
Locked
Locked Feb 10 2025
Truist Securities
Locked
Locked
Locked Feb 10 2025
Raymond James
Locked
Locked
Locked Feb 07 2025
RBC Capital
Locked
Locked
Locked Feb 07 2025
Needham
Locked
Locked
Locked Feb 07 2025
JMP Securities
Locked
Locked
Locked Feb 07 2025
Needham
Locked
Locked
Locked Jan 29 2025
Analyst Rating Date
Locked
Barclays:
Locked
Locked
Feb 10 2025
Locked
Truist Securities:
Locked
Locked
Feb 10 2025
Locked
Raymond James:
Locked
Locked
Feb 07 2025
Locked
RBC Capital:
Locked
Locked
Feb 07 2025
Locked
Needham:
Locked
Locked
Feb 07 2025
Locked
JMP Securities:
Locked
Locked
Feb 07 2025
Locked
Needham:
Locked
Locked
Jan 29 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today